Because liposarcoma is rare, commonly recurs, and has evolving treatments, it cannot be overemphasized that patients should be referred to specialized cancer treatment centers where a larger ...

Addition of the immunotherapy drug pembrolizumab to standard of care for patients with advanced soft tissue sarcoma of the ...

Boehringer Ingelheim has started a registration trial of its experimental therapy brigimadlin as a treatment for dedifferentiated liposarcoma (DDLPS), a rare cancer with limited treatment options.

More sarcoma patients are beating the odds with pembrolizumab! This immunotherapy can change the treatment for limb sarcomas ...

It was a one-in-a-million cancer, a liposarcoma, a tumor made up of fat cells gone awry. There was no way diet and exercise would help; this fat was malignant. The mass upended my life’s schedule.

In rare instances, diagnostics might reveal that a fatty lump is actually a liposarcoma — a malignant soft tissue tumor. The silver lining with liposarcomas is that they’re slow to metastasize ...

PITTSBURGH — Addition of the immunotherapy drug pembrolizumab to standard of care for patients with advanced soft tissue ...

While harmless, lipomas can resemble a rare type of cancer called liposarcoma. See your doctor if you notice any type of lump ...

在癌症治疗领域中，研究人员不断揭示新的机制，以便更好地理解肿瘤如何规避治疗并迅速进化。近年来，染色体外DNA（extrachromosomal DNA, ecDNA）的发现为理解癌症的发生、进展及耐药机制提供了 ...

The Taiwanese biotech has launched a phase 1/2 trial to test its small molecule cancer therapy in children and young adults ...

Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company working to redefine the treatment of solid tumor cancers with cell therapy, today announced presence and presentations at key scientific and ...

Addition of the immunotherapy drug pembrolizumab to standard of care for patients with advanced soft tissue sarcoma of the ...